Tigecycline: In Community-Acquired Pneumonia

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.18, 2008-01, pp. : 2633-2644

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Community‐Acquired Pneumonia

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 3, 2004-09 ,pp. : 212-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of Community-Acquired Pneumonia in Children

By Chetty Krishne Thomson Anne H.

Pediatric Drugs, Vol. 9, Iss. 6, 2007-01 ,pp. : 401-411

Adis International

Access to resources Recommend Favorite

Current treatment of community-acquired pneumonia

By Liapikou Adamantia

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1319-1332

Informa Healthcare

Access to resources Recommend Favorite

Therapies in development for community-acquired pneumonia

By Tarsia Paolo Blasi Francesco Cazzola Mario Cosentini Roberto Braga Piercarlo

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 4, 2002-04 ,pp. : 545-552

Informa Healthcare

Access to resources Recommend Favorite

Infliximab/methotrexate: Community-acquired pneumonia: case report

Reactions Weekly, Vol. 1, Iss. 1083, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite